Dale Conaway

Dale Conaway

Director/Board Member at BIOXYTRAN, INC.

Net worth: 11 754 $ as of 2026-05-30

71 year
Health Technology
Consumer Services
Government

Profile

Dr. Dale H.
Conaway
is an Independent Director at BioXyTran, Inc. and a Chief Veterinary Medical Officer at Office of Research Oversight.
He is on the Board of Directors at BioXyTran, Inc. Dr. Conaway was previously employed as an Independent Director by Boston Therapeutics, Inc., a Medical Officer-Veterinary by Federal Research, Inc., a Manager-Equine Drug Testing & Animal Disease by Michigan Department of Agriculture, a Manager-Regulatory Affairs by Michigan Department of Health & Human Services, and an Independent Director by Oxygen Therapy, Inc. He also served on the board at Avanyx Therapeutics, Inc., Pro-Pharmaceuticals, Inc. and BioXyTran, Inc. /Old/.
He received his graduate degree from the College of Veterinary Medicine and a doctorate degree from Tuskegee University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-11-13 379,177 ( 0.87% ) 11 754 $ 2026-05-30

Dale Conaway active positions

CompaniesPositionStart
BIOXYTRAN, INC. Director/Board Member 2018-11-01
Office of Research Oversight
Chief Tech/Sci/R&D Officer -

Former positions of Dale Conaway

CompaniesPositionEnd
Director/Board Member 2018-08-02
NANOMIX CORPORATION Director/Board Member 2016-09-14
Director/Board Member 2010-11-29
GALECTIN THERAPEUTICS INC. Director/Board Member 2009-02-11
Corporate Officer/Principal 2006-01-01
See the detail of Dale Conaway's experience

Training of Dale Conaway

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

32

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Consumer Services

Government

Health Technology

Consumer Services

Office of Research Oversight

Health Technology

Health Technology

Health Technology

Michigan Department of Health & Human Services

Commercial Services

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!